Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2025 24.40%
December 31, 2024
September 30, 2024 22.49%
June 30, 2024 23.17%
March 31, 2024 23.85%
December 31, 2023 23.64%
September 30, 2023 22.65%
June 30, 2023 21.75%
March 31, 2023 23.40%
December 31, 2022 21.21%
September 30, 2022 21.40%
June 30, 2022 21.78%
March 31, 2022 21.00%
December 31, 2021 21.56%
September 30, 2021 20.43%
June 30, 2021 20.80%
March 31, 2021 20.11%
December 31, 2020 20.39%
September 30, 2020 19.87%
June 30, 2020 20.94%
March 31, 2020 19.41%
December 31, 2019 19.12%
September 30, 2019 20.67%
June 30, 2019 20.39%
March 31, 2019 20.17%
Date Value
December 31, 2018 19.02%
September 30, 2018 20.92%
June 30, 2018 20.29%
March 31, 2018 20.39%
December 31, 2017 20.23%
September 30, 2017 19.83%
June 30, 2017 19.90%
March 31, 2017 19.37%
December 31, 2016 19.09%
September 30, 2016 19.37%
June 30, 2016 19.62%
March 31, 2016 19.13%
December 31, 2015 19.76%
September 30, 2015 19.23%
June 30, 2015 18.89%
March 31, 2015 19.00%
December 31, 2014 19.81%
September 30, 2014 19.33%
June 30, 2014 18.94%
March 31, 2014 18.67%
December 31, 2013 19.73%
September 30, 2013 18.80%
June 30, 2013 18.89%
March 31, 2013 19.11%
December 31, 2012 19.37%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Medifast, Inc. 69.90%
Integrated BioPharma, Inc. 0.29%
Wal-Mart de México SAB de CV 23.96%
Skinvisible, Inc. 0.00%
Kimberly-Clark de México SAB de CV 41.64%